1. Home
  2. SAGE vs BSVN Comparison

SAGE vs BSVN Comparison

Compare SAGE & BSVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • BSVN
  • Stock Information
  • Founded
  • SAGE 2010
  • BSVN 2004
  • Country
  • SAGE United States
  • BSVN United States
  • Employees
  • SAGE N/A
  • BSVN N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • BSVN Major Banks
  • Sector
  • SAGE Health Care
  • BSVN Finance
  • Exchange
  • SAGE Nasdaq
  • BSVN Nasdaq
  • Market Cap
  • SAGE 444.1M
  • BSVN 407.5M
  • IPO Year
  • SAGE 2014
  • BSVN 2018
  • Fundamental
  • Price
  • SAGE $7.31
  • BSVN $40.12
  • Analyst Decision
  • SAGE Hold
  • BSVN Buy
  • Analyst Count
  • SAGE 20
  • BSVN 2
  • Target Price
  • SAGE $10.67
  • BSVN $53.50
  • AVG Volume (30 Days)
  • SAGE 1.8M
  • BSVN 15.0K
  • Earning Date
  • SAGE 02-11-2025
  • BSVN 04-11-2025
  • Dividend Yield
  • SAGE N/A
  • BSVN 2.39%
  • EPS Growth
  • SAGE N/A
  • BSVN 58.69
  • EPS
  • SAGE N/A
  • BSVN 4.84
  • Revenue
  • SAGE $41,243,000.00
  • BSVN $97,449,000.00
  • Revenue This Year
  • SAGE $123.13
  • BSVN N/A
  • Revenue Next Year
  • SAGE $69.65
  • BSVN $3.79
  • P/E Ratio
  • SAGE N/A
  • BSVN $8.29
  • Revenue Growth
  • SAGE N/A
  • BSVN 37.95
  • 52 Week Low
  • SAGE $4.62
  • BSVN $26.07
  • 52 Week High
  • SAGE $23.22
  • BSVN $50.26
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 60.55
  • BSVN 33.98
  • Support Level
  • SAGE $7.00
  • BSVN $41.50
  • Resistance Level
  • SAGE $7.26
  • BSVN $43.76
  • Average True Range (ATR)
  • SAGE 0.19
  • BSVN 1.18
  • MACD
  • SAGE -0.06
  • BSVN -0.12
  • Stochastic Oscillator
  • SAGE 57.14
  • BSVN 0.00

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About BSVN Bank7 Corp. Common stock

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a wide variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. it offers commercial real estate lending, hospitality lending, energy lending, and commercial and industrial lending, and also provides consumer lending services to individuals.

Share on Social Networks: